- Home
- PMCB vs OP Comparison
PMCB vs OP Comparison
Compare PMCB & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- OP
- Stock Information
- Founded
- PMCB 1996
- OP 2021
- Country
- PMCB United States
- OP Greece
- Employees
- PMCB N/A
- OP N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- OP
- Sector
- PMCB Health Care
- OP
- Exchange
- PMCB Nasdaq
- OP Nasdaq
- Market Cap
- PMCB 10.9M
- OP 10.5M
- IPO Year
- PMCB N/A
- OP N/A
- Fundamental
- Price
- PMCB $1.55
- OP $1.17
- Analyst Decision
- PMCB
- OP
- Analyst Count
- PMCB 0
- OP 0
- Target Price
- PMCB N/A
- OP N/A
- AVG Volume (30 Days)
- PMCB 13.1K
- OP 25.5K
- Earning Date
- PMCB 12-13-2024
- OP 12-20-2024
- Dividend Yield
- PMCB N/A
- OP N/A
- EPS Growth
- PMCB N/A
- OP N/A
- EPS
- PMCB 0.74
- OP N/A
- Revenue
- PMCB N/A
- OP $25,729,000.00
- Revenue This Year
- PMCB N/A
- OP N/A
- Revenue Next Year
- PMCB N/A
- OP N/A
- P/E Ratio
- PMCB $2.11
- OP N/A
- Revenue Growth
- PMCB N/A
- OP 36.33
- 52 Week Low
- PMCB $1.39
- OP $1.02
- 52 Week High
- PMCB $2.58
- OP $3.15
- Technical
- Relative Strength Index (RSI)
- PMCB 40.08
- OP 36.11
- Support Level
- PMCB $1.60
- OP $1.02
- Resistance Level
- PMCB $1.62
- OP $1.17
- Average True Range (ATR)
- PMCB 0.08
- OP 0.07
- MACD
- PMCB -0.01
- OP -0.00
- Stochastic Oscillator
- PMCB 7.84
- OP 37.80
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.